About CNX Therapeutics
CNX Therapeutics is a Healthcare company based in London (United Kingdom) founded in 2021. Distributor of specialty drugs. CNX Therapeutics has completed 1 acquisition, including Synchrony Pharma. Its focus areas include Pharmaceutical Distributors and Specialty Drugs. Its legal entity is CNX THERAPEUTICS LIMITED. Its competitors include Xiel, Bartec Technologies and SPL Pharma.
Company details
CNX Therapeutics was founded in 2021 and is based in London, United Kingdom. Operations are centered on the distribution of specialty drugs within the pharmaceutical sector. Therapeutic products are supplied to healthcare providers and institutions across the region. The companys domain, cnx-therapeutics.com, supports its online activities. Focus is placed on efficient logistics and regulatory compliance in drug handling. (62 words)
- Headquarters London, United Kingdom
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website cnx-therapeutics.com
- Legal Name Cnx Therapeutics Limited
- Date of Incorporation 01 May, 1997
- Jurisdiction LONDON, ENGLAND
- Investments & Acquisitions
People of CNX Therapeutics
15 people are tracked at CNX Therapeutics (9 in leadership, 6 in team).
| Name | Role | Group |
|---|---|---|
Matthew Barker | Vice President, Transformation & Strategy | Leadership |
Dr Benjamin Moore | Vice President Corporate Development | Leadership |
Guy Clark | Chief Executive Officer | Leadership |
Sarah Morbey | Vice President, Legal & ESG | Leadership |
Lee Debenham | Director, Scientific Affairs | Leadership |
Claire Masterson | Chief Financial Officer | Leadership |
Alison Comber | Director Of Strategic Projects | Leadership |
Matthew Way | Supply Chain Director | Leadership |
Alberto Escobar | Head Of International Partner Markets | Leadership |
Miguel Sabariego | Senior Business Development Manager | Team |
Anneka P. | Senior Manager - Pharmacovigilance And Medical Information | Team |
Emmanuelle Desverchere | Country Manager France And French Speaking African Countries | Team |
Fiona Muysert | Financial Controller | Team |
Sarah-Jane Purser | Senior Legal Counsel | Team |
Anita Hansraj | Senior Supply Chain Manager, Europe | Team |
Complete people profiles for CNX Therapeutics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CNX Therapeutics
CNX Therapeutics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Synchrony Pharma.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Generic drugs are manufactured by Synchrony Pharma in the UK. | synchronypharma.com | Stevenage, United Kingdom | 2008 | Jul 2022 | •••• |
Complete acquisition details for CNX Therapeutics
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of CNX Therapeutics
2 dated milestones of CNX Therapeutics across 1 years, from founding to its latest funding, stage changes and deals.
- Founded CNX Therapeutics is founded.
- Acquisition Acquires Synchrony Pharma.
Competitors of CNX Therapeutics
CNX Therapeutics has 3 listed competitors in our database. They include Xiel, Bartec Technologies and SPL Pharma.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| xiel.co.uk | 2019 | Somerset, United Kingdom | Specialist nuclear medicine and radiotherapy solutions are distributed. | |||
| bartectechnologies.com | 1998 | Farnborough, United Kingdom | Mediso: Advanced medical imaging systems and radioactive sources | |||
| splpharma.co.uk | 2016 | London, United Kingdom | International distribution of specialty medicines and pharmaceutical market access services. |
Detailed competitors of CNX Therapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of CNX Therapeutics
The website of CNX Therapeutics (cnx-therapeutics.com) receives about 7.6K visits a month.
- Monthly visits7.6K
▲ 8.1% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cnx Therapeutics
Complete news archive for CNX Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CNX Therapeutics
CNX Therapeutics was founded in 2021.
CNX Therapeutics is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
CNX Therapeutics was founded in 2021 and is based in London, United Kingdom. Operations are centered on the distribution of specialty drugs within the pharmaceutical sector. Therapeutic products are supplied to healthcare providers and institutions across the region. The companys domain, cnx-therapeutics.com, supports its online activities. Focus is placed on efficient logistics and regulatory compliance in drug handling. (62 words).
CNX Therapeutics's top competitors include Xiel, Bartec Technologies and SPL Pharma.
CNX Therapeutics has made 1 acquisition, including Synchrony Pharma.
CNX Therapeutics operates through Cnx Therapeutics Limited.